4.3 Article

Epidemiology and Clinical Characteristics of Presumed Ocular Histoplasmosis in Olmsted County, Minnesota

Journal

OCULAR IMMUNOLOGY AND INFLAMMATION
Volume 30, Issue 5, Pages 1039-1043

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/09273948.2020.1859549

Keywords

Presumed ocular histoplasmosis syndrome; epidemiology; choroidal neovascularization

Categories

Funding

  1. National Institute on Aging of the National Institutes of Health [R01AG034676]

Ask authors/readers for more resources

This study describes the epidemiology and clinical features of presumed ocular histoplasmosis syndrome (POHS) in a Midwestern U.S. county. The incidence rate was 1.35 per 100,000 per year, with a prevalence rate of 0.064%, and approximately 17.4% of affected eyes developed choroidal neovascularization.
Purpose: To describe the incidence, prevalence, and clinical characteristics of presumed ocular histoplasmosis syndrome (POHS) in a Histoplasma endemic region. Methods: The International Classification of Diseases, 9(th) and 10(th) Revision codes were used to search the Rochester Epidemiology Project, a record-linkage system for medical care provided in Olmsted County, MN. Medical records were reviewed to confirm POHS diagnoses in county residents from January 1, 2006, to December 31, 2015. Age- and sex-adjusted incidence rates were calculated and adjusted to the 2010 U.S. White population. Results: There were 18 incident cases (30 eyes) and 87 prevalent cases (131 eyes). The incidence rate was 1.35 per 100,000 per year. The mid-study prevalence rate was 0.064%. Choroidal neovascularization (CNV) occurred in 17.4% of the affected eyes. At the last follow-up, 16.8% of the affected eyes had POHS-related decreased visual acuity (<20/40). Conclusion: This study assesses the epidemiology and clinical features of POHS in a Midwestern U.S. county. POHS = Presumed ocular histoplasmosis syndrome; ICD = International Classification of Diseases; CI = Confidence interval; VA = Visual acuity; Anti-VEGF = Anti-vascular endothelial growth factor; REP = Rochester Epidemiology Project, CNV = Choroidal neovascularization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available